Cytokinetics | CYTK - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Arca Biopharma USD 268.47M 218.95M 2026-06
Bayer EUR 4.29B 1.44B 2026-06
Biogen USD 1.28B 2.1B 2026-06
Brainstorm Cell Therapeutics USD 22K 7K 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Capricor Therapeutics USD 20.94M 84.49M 2026-06
Cytokinetics USD 255.27M 125.43M 2026-06
Eisai JPY 245.42B 56.22B 2026-03
Eli Lilly USD 8.95B 3.67B 2026-06
Exelixis USD 281.45M 55.3M 2026-06
Geron USD 62.64M 6.25M 2026-06
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Ligand Pharmaceuticals USD 1.01B 891.62M 2026-06
Merck USD 6.85B 1.52B 2026-06
Novartis USD 7.62B 739M 2026-06
Pfizer USD 976M 727M 2026-06
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 6.35B 806M 2026-06